Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]La Jolla Pharmaceutical Company"
Count: 37
Selected: 0
NCT IDTitle
NCT03381833A Study With LJPC-401 for the Treatment of Myocardial Iron Overload in Patients With Transfusion-Dependent Beta Thalassemia
NCT03395704A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis
NCT03623529A Study of LJPC-501 in Paediatric Patients With Hypotension Associated With Distributive or Vasodilatory Shock
NCT03431077A Study of LJPC-501 in Pediatric Patients With Hypotension
NCT02338843A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
NCT03245528Expanded Access for LJPC-501
NCT02155673A Phase 2 Extension Study of Study GCS-100-CS-4002
NCT01906307A Phase 1 Study of LJPC-501 in Patients With Hepatorenal Syndrome
NCT01843790A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
NCT00390091Study of LJP 394 (Abetimus Sodium) in Lupus Patients
NCT02312050A Phase 2b Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes
NCT02333955A Phase 2 Extension of Study GCS-100-CS-4003
NCT00776802GCS-100LE in Combination With Etoposide and Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
NCT00609817Safety and Efficacy Study of GCS-100LE in the Treatment of Multiple Myeloma
NCT01717248Safety Study of GCS-100 to Treat Chronic Kidney Disease
NCT00514696Study of the Safety of GCS-100 in Subjects With Chronic Lymphocytic Leukemia
NCT00089804Study of LJP 394 in Lupus Patients With History of Renal Disease
NCT00035308Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease
NCT04901169Angiotensin II in Liver Transplantation
NCT04904562Angiotensin II for Distributive Shock
NCT04529005Angiotensin II in the Perioperative Management of Hypotension in Kidney Transplant Recipients
NCT05193370Pilot RCT of Angiotensin II vs. Vasopressin in Septic Shock
NCT01978938Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections
NCT01844856Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections
NCT03032510Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections
NCT02784704Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections
NCT01265784Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections
NCT01941446A Thorough QT/QTc Study to Evaluate the Effects of an Intravenous Infusion of Eravacycline (TP-434) on Cardiac Repolarization
NCT03691584Phase 1, Safety and Bronchopulmonary PK Study in Healthy Volunteers
NCT03450187A Phase 1 TP-271 Oral PK Multiple Ascending Dose Study
NCT02135302A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With Impaired Hepatic Function and Healthy Subjects
NCT02135276A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With End Stage Renal Disease and Healthy Subjects
NCT01989949Safety and Pharmacokinetic (PK) Study to Assess Bronchopulmonary Disposition of IV Eravacycline (TP-434) in Healthy Men and Women
NCT03234738A Phase 1 Safety and PK Study of IV TP-271
NCT03024034A Phase 1 TP-271 Oral PK Single Ascending Dose Study
NCT02724085A Phase 1 Study to Assess the Safety, Tolerability and PK of IV TP-271
NCT03696550A Safety and PK Study of IV Eravacycline